Alyse Winchester Staley, MS
Research Instructor, Pediatrics-Endocrinology

Publications

• Habenicht LM, Staley AW, Clancy BM, Bozan S, Manuel CA, Fong DL, Nicklawsky AG, Klug A, Leszczynski JK. Characterization of a Jumping Stereotypy in Gerbils (Meriones unguiculatus) and Assessment of Opaque Tubing Enrichment on Stereotypies and Breeding. J Am Assoc Lab Anim Sci. 2022 Mar 1;61(2):149-158. doi: 10.30802/AALAS-JAALAS-21-000101. Epub 2022 Feb 9. PubMed PMID: 35140007; PubMed Central PMCID: PMC8956210.
• Jennifer K. Richer, Nicole S. Spoelstra, Alyse Winchester, Julia Wulfkuhle, Sharon B. Sams, Gregory Vidal, Peter Kabos, Jennifer Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Virginia Borges, Dexiang Gao, Emanuel Petricoin, Anthony D. Elias. Laboratory analyses of metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamide [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2867.
• Denise Smith (Poster): Smith, D.C., Barton, A.J., Hernandez, T.L., Thumm, E.B., Willems, E.L., Staley, A.W., & Sheeder, J.L. (2022, May 22-26). Health system factors and racial and ethnic disparities in cesarean birth utilization among low-risk women. [Poster presentation]. American College of Nurse-Midwives, Chicago, IL
• Denise Smith (Poster): Smith, D.C., Barton, A.J, Hernandez, T.L, Willems, E.L, Reed, S.M, Staley, A.W., Centi, S., & Anderson, J.L. (2022, May 22-26). The impact of a sudden shift to telehealth during the COVID19 pandemic on prenatal care and birth outcomes in a large nurse-midwifery service. [Poster presentation]. American College of Nurse-Midwives, Chicago, IL.
• Elias A, Fornier M, Vidal G, Petricoin EF, Zolman K, Biller S, Alami V, Staley AW, McSpadden T, Borges VF, Gao D, Richer JF. Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- breast cancer. Abstract ID: 1310755: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, Tx; American Association for Cancer Research; c2022
• Winchester AK, Peterson RA, Carter E, Sammel MD. Impact of COVID-19 Social Distancing Policies on Traffic Congestion, Mobility, and NO2 Pollution. Sustainability. 2021; 13(13):7275. https://doi.org/10.3390/su13137275
• Jennifer K. Richer, Nicole S. Spoelstra, Alyse Winchester, Julia Wulfkuhle, Sharon B. Sams, Gregory Vidal, Peter Kabos, Jennifer Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Virginia Borges, Dexiang Gao, Emanuel Petricoin, Anthony D. Elias. Laboratory analyses of metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamide [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2867.
• Anthony D Elias, Monica Fournier, Gregory A Vidal, Sharon Sams, Nicole Spoelsta, Peter Kabos, Jennifer R Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Julia Wulfkuhle, Emanuel Petricoin, Lisa Carter, Kathryn Zolman, Stephanie Armstead, Alyse Winchester, Tessa McSpadden, Gloria Crawford, Virginia Borges, Dexiang Gao, Jennifer Richer. Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2- primary breast cancer (BC) [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS12-06.
• Anthony D Elias, Nicole Spoelsta, Gregory A Vidal, Sharon Sams, Peter Kabos, Jennifer R Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Lisa Carter, Kathryn Zolman, Stephanie Armstead, Alyse Winchester, Virginia Borges, Julia Wulfkuhle, Emanuel Petricoin, Dexiang Gao, Jennifer Richer. Phase II trial of fulvestrant plus enzalutamide in ER+/Her2- advanced breast cancer [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS12-14.
• Anosheh Afghahi, Sydney Marsh, Alyse Winchester, Dexiang Gao, Hannah Parris, Lisen Axell, Leif W. Ellisen, Erin Wysong Hofstatter, Allison W. Kurian, Marie Wood, Dana Zakalik, Carol-Ann Mullin, Jennifer Lee Caswell-Jin, Virginia F. Borges, Nadine M. Tung. Twenty-one-gene recurrence score (RS) in germline (g)CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study [abstract]. Journal of Clinical Oncology 2021 39:15_suppl, 10531-10531
• Richer J, Spoelstra N, Winchester A, Wulfkuhle J, Sams S, Vidal G, Kabos P, Diamond J, Shagisultanova E, Afghahi A, Mayordomo J, McSpadden T, Crawford G, Borges V, Gao D, Petricoin E, Elias A. Abstract 2867: Laboratory analyses of metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamide. Tumor Biology. Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA; ; American Association for Cancer Research; c2021. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.AM2021-2867 DOI: 10.1158/1538-7445.AM2021-2867
• Afghahi A, Marsh S, Winchester A, Gao D, Parris H, Axell L, Ellisen L, Hofstatter E, Kurian A, Wood M, Zakalik D, Mullin C, Caswell-Jin J, Borges V, Tung N. Twenty-one-gene recurrence score (RS) in germline (g) CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):10531-10531. Available from: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.10531 DOI: 10.1200/JCO.2021.39.15_suppl.10531
• Elias A, Fournier M, Vidal G, Sams S, Spoelsta N, Kabos P, Diamond J, Shagisultanova E, Afghahi A, Mayordomo J, Wulfkuhle J, Petricoin E, Carter L, Zolman K, Armstead S, Winchester A, McSpadden T, Crawford G, Borges V, Gao D, Richer J. Abstract PS12-06: Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2- primary breast cancer (BC). Poster Session Abstracts. Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas; ; American Association for Cancer Research; c2021. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.SABCS20-PS12-06 DOI: 10.1158/1538-7445.SABCS20-PS12-06
• Elias A, Spoelsta N, Vidal G, Sams S, Kabos P, Diamond J, Shagisultanova E, Afghahi A, Mayordomo J, McSpadden T, Crawford G, Carter L, Zolman K, Armstead S, Winchester A, Borges V, Wulfkuhle J, Petricoin E, Gao D, Richer J. Abstract PS12-14: Phase II trial of fulvestrant plus enzalutamide in ER+/Her2- advanced breast cancer. Poster Session Abstracts. Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas; ; American Association for Cancer Research; c2021. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.SABCS20-PS12-14 DOI: 10.1158/1538-7445.SABCS20-PS12-14
• Winchester A, Peterson R, Carter E, Sammel M. Impact of COVID-19 Social Distancing Policies on Traffic Congestion, Mobility, and NO2 Pollution. Sustainability. 2021 June 29; 13(13):7275-. Available from: https://www.mdpi.com/2071-1050/13/13/7275 DOI: 10.3390/su13137275